The 10-patient trial will take place at Rabin Medical Center Golda HaSharon Campus in Petah Tikva

The recalled product was sold in B.C., Alberta, and Manitoba from March 13 to 24.

The study focused on how high-CBD extracts affected the proteins through which the virus enters host cells

A $483 billion interim coronavirus relief package excludes cannabis companies from receiving aid

The benefits of psychedelics have been known for decades, but 2020 promises to be a big year with investment ramping up clinical trials

The study is looking at whether or not cannabidiol can slow down inflammation in severe cases of coronavirus infection